Skip to main content
. 2016 Jan;8(1):98–115. doi: 10.3978/j.issn.2072-1439.2016.01.28

Figure 2.

Figure 2

Network of studies comparing objective response rate of different agents for unselected patients with advanced non-small cell lung cancer. Each link represents at least one study, width of each link is number of trials per comparison, size of each node is proportional to the total sample size. CT, chemotherapy; Bev, bevacizumab; Gef, gefitinib; Erl, erlotinib; Cet, cetuximab.